Smooth muscle K+ channel openers; their pharmacology and clinical potential
- 1 January 1989
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 414 (S1) , S99-S105
- https://doi.org/10.1007/bf00582256
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- The Mode of Action of Pinacidil and Its Analogs P1060 and P1368Journal of Cardiovascular Pharmacology, 1988
- Double-Blind Comparator Trials with Pinacidil, a Potassium Channel OpenerDrugs, 1988
- Effects of Long Term Treatment with Pinacidil and Nifedipine on Left Ventricular Anatomy and Function in Patients with Mild to Moderate Systemic HypertensionDrugs, 1988
- Effects of Pinacidil on Bladder MuscleDrugs, 1988
- Leiurus quinquestriatus venom inhibits BRL 34915-induced 86Rb+ efflux from the rat portal veinLife Sciences, 1988
- Clinical Pharmacology of Pinacidil, A Prototype for Drugs That Affect Potassium ChannelsJournal of Cardiovascular Pharmacology, 1988
- BRL 34915, A Novel Antihypertensive Agent: Comparison of Effects on Blood Pressure and Other Haemodynamic Parameters with Those of Nifedipine in Animal ModelsJournal of Cardiovascular Pharmacology, 1987
- Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG-75)Journal of Cardiovascular Pharmacology, 1983
- Hemodynamic Characterization of Pinacidil in RatsPharmacology, 1983